Reports
Sale
Global Metagenomics Market Size, Trends, Analysis, Forecast: By Product and Services: Software, Kits and Reagents, Sequencing and Data Analytics Services; By Technology: Shotgun Sequencing, 16S Sequencing, Whole Genome Sequencing, Others; By Application; Regional Analysis; Market Dynamics; Supplier Landscape; 2024-2032
Global Metagenomics Market Outlook
The global metagenomics market size was valued at USD 738.1 million in 2023, driven by the rising emphasis on dealing with antibiotic resistance. The market is expected to grow at a CAGR of 14.2% during the forecast period of 2024-2032, with the values likely to rise from USD 842.5 million in 2024 to USD 2429.3 million by 2032.
Metagenomics: Introduction
Metagenomics is the study of complex microbial communities in their natural habitat. It involves whole genome sequencing analysis of an entire community of microorganisms that may be present on and in the body (animals, humans, fish, or insects), air, soil, water samples and food. Metagenomics involves several tools, techniques, and approaches that allow direct and total genetic analysis. It is widely recommended as it allows the diagnosis of unculturable microorganisms via genomic assemblies.
Global Metagenomics Market Analysis
Metagenomics has found its application in several domains, including climate challenges, clinical diagnostics, food and nutrition, veterinary diagnostics and more. Consequently, the demand has seen a significant pick-up in recent years. The metagenomics market growth is driven by the advent of technically advanced techniques like targeted metagenomic sequencing and shotgun sequencing.
With the growing prevalence of chronic illnesses, there has been significant concentration on speeding up drug development across the globe. In May 2023, Ginkgo Bioworks and Boehringer Ingelheim entered a strategic partnership to put Ginkgo’s metagenomic sequence database to use and search and accelerate the drug discovery process, particularly for ailments with unmet patient needs. Such mergers are a clear indication that the metagenomics market demand will witness substantial progress during the forecast period.
The market growth is driven by the increasing emphasis on combating antimicrobial resistance. Antibiotic resistance bloodstream infections have been a growing area of concern amongst scientists. Bloodstream infections may lead to multiple organ failure, sepsis and even death, as a result, early and apt therapy is highly critical to control the infection. When compared to conventional methods, metagenomic sequencing provides rapid and precise research results, making it a preferred alternative for researchers.
Global Metagenomics Market Segmentation
Market Breakup by Product and Services
- Software
- Kits and Reagents
- Sequencing and Data Analytics Service
Market Breakup by Technology
- Shotgun Sequencing
- 16S Sequencing
- Whole Genome Sequencing
- Others
Market Breakup by Application
- Environmental Application
- Clinical Diagnostics Applications
- Soil Microbiome Applications
- Drug Discovery Applications
- Biotechnology Applications
- Food and Nutrition Applications
- Veterinary Applications
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Metagenomics Market Overview
The United States accounted for a significant part of the metagenomics market share during the historical period. The market share can be attributed to the region’s well-structured pharmaceutical and biotechnology industries, along with increasing government funding for genomics research. The rising focus of key healthcare players around offering personalised medicine to patients has also been contributing significantly to the market growth.
Europe has been historically dominating the global market with a robust healthcare and research infrastructure. Projects like the MetaHIT, which aimed at leveraging metagenomics to establish relations between the genes of the human intestinal microbiota, along with health and disease, can be a prime example demonstrating the region’s commitment to promoting innovation amongst researchers.
The Asia Pacific metagenomics market value is projected to emerge strongly in upcoming years. With increasing awareness and investigations into genomic research, the research is expanding the infrastructure for better facilities. The potential applications of metagenomics across various domains including agricultural and environmental studies have led to boosted research initiatives and funding for the same.
Global Metagenomics Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Agilent Technologies, Inc
- ENTEROME
- IntegraGen
- Oxford Nanopore Technologies
- QIAGEN
- Illumina, Inc
- Pacific Biosciences of California, Inc
- Swift Biosciences Inc.
- Thermo Fisher Scientific Inc.
- BGI
- Bio-Rad Laboratories, Inc.
- Promega Corporation
- Computomics Gmbh.
- Microsynth AG
- Arc Bio LLC
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product and Services |
|
| Breakup by Technology |
|
| Breakup by Application |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Metagenomics Market Overview
3.1 Global Metagenomics Market Historical Value (2017-2023)
3.2 Global Metagenomics Market Forecast Value (2027-2032)
4 Global Metagenomics Market Landscape
4.1 Global Metagenomics Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Metagenomics Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
5 Global Metagenomics Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Metagenomics Market Segmentation
6.1 Global Metagenomics Market by Product and Services
6.1.1 Market Overview
6.1.2 Software
6.1.3 Kits and Reagents
6.1.4 Sequencing and Data Analytics Services
6.2 Global Metagenomics Market by Technology
6.2.1 Market Overview
6.2.2 Shotgun Sequencing
6.2.3 16S Sequencing
6.2.4 Whole Genome Sequencing
6.2.5 Others
6.3 Global Metagenomics Market by Application
6.3.1 Market Overview
6.3.2 Environmental Application
6.3.3 Clinical Diagnostics Applications
6.3.4 Soil Microbiome Applications
6.3.5 Drug Discovery Applications
6.3.6 Biotechnology Applications
6.3.7 Food and Nutrition Applications
6.3.8 Veterinary Applications
6.3.9 Others
6.4 Global Metagenomics Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Metagenomics Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Metagenomics Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Metagenomics Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Metagenomics Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Metagenomics Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Agilent Technologies, Inc
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 ENTEROME
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 IntegraGen
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Oxford Nanopore Technologies
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 QIAGEN
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Illumina, Inc
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Pacific Biosciences of California, Inc
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Swift Biosciences Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Thermo Fisher Scientific Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 BGI
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Bio-Rad Laboratories, Inc.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Promega Corporation
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Computomics Gmbh.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Microsynth AG
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Arc Bio LLC
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
18 Global Metagenomics Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 738.1 million in 2023, driven by the emphasis on combating antimicrobial resistance across the globe.
The market is anticipated to grow at a CAGR of 14.2% during the forecast period of 2024-2032, likely to reach a market value of USD 2429.3 million by 2032.
The market demand is driven by the continuous advancements in sequencing technologies that have reduced the cost and time required for sequencing genetic material from complex microbial communities significantly.
The market trend is around rising applications of metagenomics for drug development. In May 2023, Ginkgo Bioworks and Boehringer Ingelheim partnered to put Ginkgo’s metagenomic sequence database for accelerated drug discovery.
The products and services can be categorised into software, kits and reagents, sequencing and data analytics services.
Based on technology, the market is segmented into shotgun sequencing, 16S sequencing, and whole genome sequencing, among others.
Metagenomic finds wide applications in environmental application, clinical diagnostics, soil microbiome, drug discovery, biotechnology, food and nutrition veterinary applications, among others.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
Key players involved in the market are Agilent Technologies, Inc, ENTEROME, IntegraGen, Oxford Nanopore Technologies, QIAGEN, Illumina, Inc, Pacific Biosciences of California, Inc, Swift Biosciences Inc., Thermo Fisher Scientific Inc., BGI, Bio-Rad Laboratories, Inc., Promega Corporation, Computomics Gmbh., Microsynth AG, and Arc Bio LLC.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER